compounded semaglutide shortage & Tirzepatide 2025: Safe Use Guide Compounded Semaglutide Shortage: Supply &

Recent trial results indicate that retatrutide may cause higher rates of gastrointestinal side effects compared with some existing obesity medications

Overview Retatrutide is a synthetic, long-acting triple agonist that targets three distinct hormonal receptors: the glucagon-like pep-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor (GCGR)

Obese Zucker rats treated with AOD-9604 at 500 mcg/kg/day for 19 days showed a statistically significant reduction in body fat compared to vehicle-treated controls

If youre curious about how GLP-1 weight loss injections can help you reduce unwanted weight in the Naperville area, give us a call at (630) 586-6278